VERACYTE, INC. Current State and Local Tax Expense (Benefit)
VERACYTE, INC. (VCYT) reported Current State and Local Tax Expense (Benefit) of $2.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-26
- VERACYTE, INC. current state and local tax expense (benefit) for fiscal 2025 was $2.31M, a 27.56% increase from fiscal 2024.
- VERACYTE, INC. current state and local tax expense (benefit) for fiscal 2024 was $1.81M, a 19.34% increase from fiscal 2023.
- VERACYTE, INC. current state and local tax expense (benefit) for fiscal 2023 was $1.52M, a 256.81% increase from fiscal 2022.
- VERACYTE, INC. current state and local tax expense (benefit) for fiscal 2022 was $426.00K, a 576.19% increase from fiscal 2021.
| Period end | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $2.31M 10-K · filed 2026-02-26 |
| 2024-12-31 | $1.81M 10-K · filed 2026-02-26 |
| 2023-12-31 | $1.52M 10-K · filed 2026-02-26 |
| 2022-12-31 | $426.00K 10-K · filed 2025-02-28 |
| 2021-12-31 | $63.00K 10-K · filed 2024-02-29 |
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |